Human lymphoblastoid cells that contain Epstein-Barr virus (EBV) restrict replication of the virus. In some human lymphoblastoid lines no viral nucleocapsids are found, yet the viral genome is detectable by nucleic acid hybridization (1, 2). In other lines nucleocapsids or viral antigens detected by immunofluorescence (immunofluorescence antigens) are produced in only a few cells, although cloning experiments demonstrate that all cells contain the viral genome (3-5). Furthermore, not all lines in which nucleocapsids or immunofluorescence antigens are found give rise to biologically active virus detectable by transformation or superinfection assays (6, 7). The mechanisms of restriction of EBV by the host cell are unknown and present important practical and theoretical problems. The lack of a cell type that yields large amounts of virus has hindered study of the virus. The means of restriction of virus by the cell deserves study as an important example of the control of gene expression.
Human lymphoblastoid cells that contain Epstein-Barr virus (EBV) restrict replication of the virus. In some human lymphoblastoid lines no viral nucleocapsids are found, yet the viral genome is detectable by nucleic acid hybridization (1, 2) . In other lines nucleocapsids or viral antigens detected by immunofluorescence (immunofluorescence antigens) are produced in only a few cells, although cloning experiments demonstrate that all cells contain the viral genome (3) (4) (5) . Furthermore, not all lines in which nucleocapsids or immunofluorescence antigens are found give rise to biologically active virus detectable by transformation or superinfection assays (6, 7) . The mechanisms of restriction of EBV by the host cell are unknown and present important practical and theoretical problems. The lack of a cell type that yields large amounts of virus has hindered study of the virus. The means of restriction of virus by the cell deserves study as an important example of the control of gene expression.
We recently reported that leukocytes from two species of new-world primates transform into continuous cell lines after exposure to EBV (8) . Certain features of these cells suggested that simian leukocytes might produce more EB virions than transformed human leukocytes. A higher fraction of monkey cells than human cells demonstrated intracellular immunofluorescence antigen. In simian cell lines syncitia evolved that were the site of accumulation of immunofluorescence antigen, and the multinucleate giant cells contained intranuclear inclusions. Accordingly, supernatant fluids of EBV-converted monkey cells were tested for the presence of cell-free virus, which was readily demonstrated. This report is concerned with identification of the extracellular virus as EBV, a description of the virus' morphology and growth characteristics, and evidence that production of extracellular EBV is due to factors inherent in the transformed cell type rather than to a permanent change in the virus resulting from passage through simian cells. METHODS Virus. Two EBV strains were derived from patients with infectious mononucleosis: one (Hawley) from peripheral Abbreviation: EBV, Epstein-Barr virus.
blood leukocytes, the other (Lederer) from a throat washing. The Hawley strain was maintained as a line of the patient's blood leukocytes (883L) or as a line of marmoset blood leukocytes (B95-8), which was established after exposure to an extract of line 883L. A virus stock from the B95-8 line consisted of culture fluids that had been centrifuged (400 X g); the supernatant had been frozen and thawed and passed through a 0.8-/Am filter and stored at -70°. Virus of the Lederer strain was obtained by having the patient gargle 100 ml of medium RPMI 1640. Fetal bovine serum (final concentration 2%) was added to gargle fluids, which were frozen and thawed three times, then centrifuged at 400 X g for 10 min; the supernatant was filtered and stored at -70°. Transforming activity in extracts of lines 883L and B95-8, and in the Lederer throat washing, was neutralized by human sera with EBV antibody and unaffected by human sera free of EBV antibody (refs. 7 Ether and Chloroform Sensitivity of EBV. The effect of lipid solvents on the transforming capacity of virus released from marmoset cells was determined as follows: 2 ml of B95-8 virus stock was mixed with 1 ml of anhydrous ethyl ether and placed at 40 for 4 hr. For chloroform treatment, 2.7 ml of B95-8 virus stock was mixed with 0.3 ml of chloroform and placed at 40 for 1 hr. The organic layers were discarded, and air was bubbled through both mixtures for 2 min. Titrations of infectivity were done on untreated B95-8 stock virus and on the aqueous phase of chloroform-treated and ether-treated virus.
Examination of EBV Particles by Electronmicroscopy. Cells were sedimented from 200 ml of culture fluid at 400 X g for 20 min. The supernatant was centrifuged at 20,000 rpm in an SW25.2 rotor at 50, and the resulting pellets were suspended in about 1/30 volume of Tris-HCl-buffered saline plus 1% bovine-serum albumin. This material was placed on top of a discontinuous gradient of 10 and 50% potassium tartrate in buffer (pH 7.4) composed of 1 M NaCl-0.1 M Tris HCl-10 mM EDTA. An interphase with an opalescent band, which appeared after centrifugation at 25,000 rpm in an SW41 rotor at 50 for 2 hr, was collected. This interphase was then centrifuged in a linear 20-30% potassium tartrate gradient for 17 hr at 25,000 rpm in an SW41 rotor. An opalescent band in the bottom one-third of the tube was collected for electronmicroscopic examination and for density determination by weighing. Aliquots from the cell culture fluids after initial clarification, from the pellet after the first high-speed centrifugation, and from the interphase after centrifugation in the discontinuous gradient were also examined by electronmicroscopy. Samples were placed on Formvar carbon-coated grids, stained with 2%o phosphotungstic acid (pH 6.0), and examined in a Phillips EM-200.
RESULTS
Transforming activity of extracellular virus from line B95-8 (marmoset cells) was neutralized by two human EBV-positive reference sera, and was unaffected by two EBV-negative human sera. Titrations of the antibody-positive sera demonstrate neutralizing activity at a 1:128 dilution or greater. When about 30,000 transforming units of extracellular virus from line B95-8 were mixed with ether or chloroform, all transforming activity was abolished.
Herpes virus nucleocapsids were seen in clarified supernatant fluid obtained 6 days after subculture of B95-8 cells. When the fluid was centrifuged at 48,000 X g, virions were found in the pellet. Similar viral particles were seen in the band between 10 and 50% potassium tartrate and in the band collected after overnight centrifugation. Debris was still present in the preparation after this step. The virions seen ( Fig. 1 ) consisted of enveloped particles as well as naked nucleocapsids. The nucleocapsids were hexagonal and of uniform size (about 100 nm). A core could be seen in many of the particles. The density of the virus-containing band after centrifugation in the 20-30% potassium tartrate linear gradient was 1.186 g/ml. When line 883L was treated in an identical manner, only a rare naked nucleocapsid was identified in the banded material.
Time course of production of extracellular EBV Extracellular virus increased in parallel with the exponential phase of cell growth (Fig. 2) Lines of transformed squirrel monkey and marmoset leukocytes were derived by exposure to EBV from line 883L (Hawley strain). EBV obtained from cell-free supernatant fluids of these three lines was used to transform cells from three umbilical cords. All six lines were carried in parallel for several months by subdividing 2: 1 every 5-7 days. Cells and fluids were harvested for determination of antigen content and infectivity 1 To establish whether these differences were peculiar to the Hawley strain of virus, which had undergone many passages in transformed human and marmoset cells, we performed further transformation studies with the Lederer strain, which was stored as a throat gargle from a patient (Table 3) Lines of human umbilical cord leukocytes and marmoset leukocytes were obtained after exposure to a throat washing. The transforming capacity of the throat washing was neutralized by EBV antibody and unaffected by EBV-free human sera. The cell lines were subdivided 2:1 every 3-5 days and tested for antigens and infectious EBV in supernatant fluids and extracts of 107 cells/ml. * See footnotes of Table 1. is from 0.25-2.6 infectious units per marmoset cell with immunofluorescence antigen, while for those transformed adult human cells that yield infectious EBV one infectious unit is released per 200-3000 cells with immunofluorescence antigen. The factors responsible for the higher yields of transforming virus per activated marmoset cell deserve further study. The most likely explanation is that envelopment of the virus proceeds more efficiently in marmoset cells. In keeping with this hypothesis, infectivity of virus from the B95-8 line was destroyed by ether and chloroform, and enveloped particles were seen by electronmicroscopy. By contrast, only a rare nucleocapsid, and no enveloped particles, were found in fluids of line 883L, which has a low titer of extracellular EBV. It is conceivable, therefore, that EB viral release from cells, in the absence of cellular degeneration, is facilitated by envelopment.
Activation of the viral genome of the transformed marmoset cells leading to release of infectious virus apparently occurs during the exponential phase of cell growth (Fig. 2) , for there was no increase in infectious virus production once the cells reached stationary phase. The availability of a line that releases biologically active virus should permit close analysis of the events in the cell cycle in which viral activation proceeds. However, it is apparent that exponential cell growth per se is insufficient to activate the genome, for biologically active virus is not released at all by transformed cord cells.
Some of the transformed cord cells have been tested for cellassociated virus; barely detectable transforming activity was found in an extract of one cord cell line and none in several others.
Finally, several biochemical, biophysical, and immunological experiments should be facilitated by the availability of a system that produces reasonably large quantities of cellfree virus that can be partially purified. One 
